{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:06:11Z","timestamp":1789362371441,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001077","name":"The Royal Brisbane and Women's Hospital Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001077","id-type":"DOI","asserted-by":"crossref"}]},{"name":"bioM\u00e9rieux"},{"name":"Australian Postgraduate Award"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ijantimicag.2014.11.015","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T01:08:25Z","timestamp":1421197705000},"page":"351-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6515-2118","authenticated-orcid":false,"given":"Benjamin A.","family":"Rogers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Runnegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Pitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua T.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Athan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Havers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna E.","family":"Sidjabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Earlleen","family":"Gunning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"De Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaylene","family":"Styles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0200","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/AAC.01025-12","article-title":"Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections","volume":"57","author":"Adams-Sapper","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0205","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/jac\/dkr349","article-title":"Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings","volume":"66","author":"Croxall","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0210","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/AAC.00297-09","article-title":"Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004","volume":"53","author":"Johnson","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0215","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/cid\/cit503","article-title":"Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans","volume":"57","author":"Colpan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkq415","article-title":"Escherichia coli O25b\u2013ST131: a pandemic, multiresistant, community-associated strain","volume":"66","author":"Rogers","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0225","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/669865","article-title":"Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts","volume":"34","author":"Banerjee","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0230","doi-asserted-by":"crossref","first-page":"e72191","DOI":"10.1371\/journal.pone.0072191","article-title":"Different factors associated with CTX-M-producing ST131 and non-ST131 Escherichia coli clinical isolates","volume":"8","author":"Nicolas-Chanoine","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0235","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/jac\/dkt405","article-title":"Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b\/ST131: risk factors and clinical implications","volume":"69","author":"L\u00f3pez-Cerero","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0240","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.urology.2012.10.056","article-title":"Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy","volume":"81","author":"Liss","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0245","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/AAC.05753-11","article-title":"Bacteremia caused by extended-spectrum-\u03b2-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality","volume":"56","author":"Chung","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0250","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/jac\/dkq098","article-title":"Escherichia coli ST131 producing CTX-M-15 in Australia","volume":"65","author":"Sidjabat","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0255","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/jac\/dkq236","article-title":"Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia","volume":"65","author":"Platell","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0260","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1128\/JCM.01315-13","article-title":"Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women","volume":"51","author":"Kudinha","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0265","doi-asserted-by":"crossref","first-page":"E173","DOI":"10.1111\/1469-0691.12123","article-title":"Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis or cystitis and healthy controls","volume":"19","author":"Kudinha","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0270","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/INF.0b013e31828ba3f1","article-title":"Genotypic and phenotypic characterization of Escherichia coli isolates from children with urinary tract infection and from healthy carriers","volume":"32","author":"Kudinha","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0275","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/cid\/cis194","article-title":"Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen","volume":"54","author":"Williamson","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0280","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1093\/jac\/dkt276","article-title":"Clinical and molecular correlates of virulence in Escherichia coli causing bloodstream infection following transrectal ultrasound-guided (TRUS) prostate biopsy","volume":"68","author":"Williamson","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0285","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1128\/AAC.00306-11","article-title":"Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia","volume":"55","author":"Platell","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0290","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/AAC.02052-13","article-title":"Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries","volume":"58","author":"Rogers","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0295","series-title":"Clinical breakpoints\u2014bacteria (v 1.3)","author":"European Committee on Antimicrobial Susceptibility and Testing","year":"2014"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0300","series-title":"Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. Document M100-S20","author":"Clinical and Laboratory Standards Institute","year":"2010"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0305","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1128\/AEM.66.10.4555-4558.2000","article-title":"Rapid and simple determination of the Escherichia coli phylogenetic group","volume":"66","author":"Clermont","year":"2000","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0310","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1128\/JCM.00528-11","article-title":"Controlled performance evaluation of the DiversiLab repetitive-sequence-based genotyping system for typing multidrug-resistant health care-associated bacterial pathogens","volume":"49","author":"Deplano","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0315","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1365-2958.2006.05172.x","article-title":"Sex and virulence in Escherichia coli: an evolutionary perspective","volume":"60","author":"Wirth","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0320","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1128\/JCM.02265-08","article-title":"Using a commercial DiversiLab semiautomated repetitive sequence-based PCR typing technique for identification of Escherichia coli clone ST131 producing CTX-M-15","volume":"47","author":"Pitout","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0325","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/JB.01524-12","article-title":"Role of homologous recombination in adaptive diversification of extraintestinal Escherichia coli","volume":"195","author":"Paul","year":"2013","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0330","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1128\/AEM.06663-11","article-title":"High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli","volume":"78","author":"Weissman","year":"2012","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0335","series-title":"Gram-negative survey. Community-onset infections. 2010 Antimicrobial susceptibility report","first-page":"1","author":"Turnidge","year":"2012"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0340","series-title":"Gram-negative survey. Hospital-onset infections. 2011 Antimicrobial susceptibility report","author":"Turnidge","year":"2012"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0345","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3201\/eid1809.111515","article-title":"Control of fluoroquinolone resistance through successful regulation, Australia","volume":"18","author":"Cheng","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0350","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/infdis\/jis933","article-title":"Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli","volume":"207","author":"Johnson","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0355","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1073\/pnas.1322678111","article-title":"Global dissemination of a multidrug resistant Escherichia coli clone","volume":"111","author":"Petty","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0360","doi-asserted-by":"crossref","first-page":"e87025","DOI":"10.1371\/journal.pone.0087025","article-title":"Virulence patterns in a murine sepsis model of ST131 Escherichia coli clinical isolates belonging to serotypes O25b:H4 and O16:H5 are associated to specific virotypes","volume":"9","author":"Mora","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0365","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/jac\/dkt519","article-title":"Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains","volume":"69","author":"Blanc","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0370","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1128\/AAC.01338-09","article-title":"High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-\u03b2-lactamase-producing Escherichia coli isolates from Canada","volume":"54","author":"Peirano","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0375","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1128\/JCM.00346-13","article-title":"Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum \u03b2-lactamase-producing E. coli isolates in Copenhagen, Denmark","volume":"51","author":"Olesen","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0380","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1128\/AAC.05824-11","article-title":"Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-\u03b2-lactamase-producing E. coli from the United States, 2000 to 2009","volume":"56","author":"Johnson","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0385","doi-asserted-by":"crossref","first-page":"e34294","DOI":"10.1371\/journal.pone.0034294","article-title":"Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131","volume":"7","author":"Lavigne","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2014.11.015_bib0390","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1128\/IAI.06388-11","article-title":"Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype","volume":"80","author":"Johnson","year":"2012","journal-title":"Infect Immun"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T05:28:07Z","timestamp":1537939687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857915000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0924857915000047"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.11.015","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}